Suppr超能文献

COVID-19 疫苗和公众焦虑:抗体检测可能会被广泛接受。

COVID-19 Vaccines and Public Anxiety: Antibody Tests May Be Widely Accepted.

机构信息

Department of Infectious Diseases, Peking University Third Hospital, Beijing, China.

Research Center of Clinical Epidemiology, Peking University Third Hospital, Beijing, China.

出版信息

Front Public Health. 2022 May 6;10:819062. doi: 10.3389/fpubh.2022.819062. eCollection 2022.

Abstract

BACKGROUND

More than 200 countries are experiencing the coronavirus disease (COVID-19) pandemic. COVID-19 vaccination strategies have been implemented worldwide, and repeat COVID-19 outbreaks have been seen. The purpose of this study was to investigate the impact of COVID-19 vaccination on the reduction of perceived anxiety and the association between public anxiety and antibody testing intention during the COVID-19 pandemic.

METHODS

Chinese adults aged 18 and over were surveyed using an anonymous online questionnaire in April and May 2021. The questionnaire collected sociodemographic characteristics, vaccination characteristics, perceived anxiety due to COVID-19, and attitudes toward future antibody testing after COVID-19 vaccination. Perceived anxiety was assessed on a visual analog scale (VAS). Multivariate logistic regression analysis was used to determine the factors influencing future antibody detection.

RESULTS

A total of 3,233 people were investigated, 3,209 valid questionnaires were collected, and the response rate was 99.3%. Of the 3,209 respondents, 2,047 were vaccinated, and 1,162 were unvaccinated. There was a significant difference in anxiety levels between vaccinated and unvaccinated respondents (24.9±25.4 vs. 50.0±33.1, respectively). With the local spread of COVID-19 in mainland China, the public anxiety VAS scores increased by 15.4±25.6 (SMD=120%) and 33.8±31.7 (SMD=49%) among vaccinated and unvaccinated respondents, respectively. Of the 2,047 respondents who were vaccinated, 1,626 (79.4%) thought they would accept antibody testing. Those who displayed more anxiety about acquiring COVID-19 disease were more likely to accept COVID-19 antibody testing. If the antibody test results showed protective antibodies, 1,190 (58.1%) were more likely to arrange travel plans in China, while 526 (25.7%) thought they would feel safer traveling abroad.

CONCLUSION

COVID-19 vaccination strategies help reduce public anxiety. However, public anxiety may be elevated as the local transmission of COVID-19 occurs in mainland China, which is usually caused now by imported cases. Those who display more anxiety choose to have antibody testing. Improving the accessibility of COVID-19 antibody tests can help ease public anxiety and enhance the confidence of some people to participate in social activities.

摘要

背景

超过 200 个国家正在经历冠状病毒病(COVID-19)大流行。全球范围内已经实施了 COVID-19 疫苗接种策略,并出现了重复的 COVID-19 爆发。本研究的目的是探讨 COVID-19 疫苗接种对减轻感知焦虑的影响,以及公众焦虑与 COVID-19 疫苗接种后抗体检测意愿之间的关联。

方法

2021 年 4 月至 5 月,使用匿名在线问卷对中国 18 岁及以上的成年人进行了调查。问卷收集了社会人口统计学特征、疫苗接种特征、COVID-19 引起的感知焦虑以及 COVID-19 疫苗接种后对未来抗体检测的态度。感知焦虑采用视觉模拟量表(VAS)进行评估。采用多变量逻辑回归分析确定影响未来抗体检测的因素。

结果

共调查了 3233 人,回收了 3209 份有效问卷,应答率为 99.3%。在 3209 名应答者中,有 2047 人接种了疫苗,1162 人未接种疫苗。接种组和未接种组的焦虑水平存在显著差异(分别为 24.9±25.4 和 50.0±33.1)。随着中国大陆 COVID-19 的局部传播,接种组和未接种组的公众焦虑 VAS 评分分别增加了 15.4±25.6(SMD=120%)和 33.8±31.7(SMD=49%)。在接种疫苗的 2047 名应答者中,有 1626 名(79.4%)认为他们会接受抗体检测。那些对感染 COVID-19 疾病感到更焦虑的人更有可能接受 COVID-19 抗体检测。如果抗体检测结果显示有保护性抗体,有 1190 名(58.1%)更有可能在中国安排旅行计划,而有 526 名(25.7%)认为出国旅行会更安全。

结论

COVID-19 疫苗接种策略有助于减轻公众焦虑。然而,随着中国大陆发生 COVID-19 的本地传播,公众焦虑可能会升高,而这通常是由输入性病例引起的。那些感到更焦虑的人选择进行抗体检测。提高 COVID-19 抗体检测的可及性有助于缓解公众焦虑,并增强一些人参与社会活动的信心。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f51/9120666/d0212893c8b7/fpubh-10-819062-g0001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验